As of close of business last night, Codexis Inc.’s stock clocked out at $3.76, down -10.58% from its previous closing price of $4.20. In other words, the price has decreased by -$0.4450 from its previous closing price. On the day, 824904 shares were traded.
Ratios:
To gain a deeper understanding of CDXS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 2.61. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.14.
TD Cowen Downgraded its Outperform to Market Perform on August 07, 2023, whereas the target price for the stock was revised from $21 to $4.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 15 when Dorgan Byron L sold 20,000 shares for $2.11 per share. The transaction valued at 42,168 led to the insider holds 193,461 shares of the business.
Norrett Kevin bought 9,000 shares of CDXS for $15,479 on Sep 11. The Chief Operating Officer now owns 98,102 shares after completing the transaction at $1.72 per share. On Sep 08, another insider, DILLY STEPHEN GEORGE, who serves as the insider of the company, bought 58,479 shares for $1.73 each. As a result, the insider paid 100,952 and bolstered with 438,878 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDXS now has a Market Capitalization of 264.34M and an Enterprise Value of 215.25M. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.77 while its Price-to-Book (P/B) ratio in mrq is 3.03. Its current Enterprise Value per Revenue stands at 3.07 whereas that against EBITDA is -4.80.
Stock Price History:
Over the past 52 weeks, CDXS has reached a high of $4.94, while it has fallen to a 52-week low of $1.45. The 50-Day Moving Average of the stock is 3.0360, while the 200-Day Moving Average is calculated to be 2.4757.
Shares Statistics:
It appears that CDXS traded 795.52K shares on average per day over the past three months and 1.15M shares per day over the past ten days. A total of 69.91M shares are outstanding, with a floating share count of 67.25M. Insiders hold about 4.34% of the company’s shares, while institutions hold 80.50% stake in the company. Shares short for CDXS as of Feb 15, 2024 were 2.52M with a Short Ratio of 3.17, compared to 2.48M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.60% and a Short% of Float of 3.68%.
Earnings Estimates
As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.18 for the current quarter, with a high estimate of -$0.14 and a low estimate of -$0.22, while EPS last year was -$0.34. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.18 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.57 and -$0.74 for the fiscal current year, implying an average EPS of -$0.65. EPS for the following year is -$0.68, with 6 analysts recommending between -$0.53 and -$0.83.
Revenue Estimates
In the current quarter, 7 analysts expect revenue to total $13.81M. It ranges from a high estimate of $15M to a low estimate of $11.79M. As of the current estimate, Codexis Inc.’s year-ago sales were $12.98M, an estimated increase of 6.40% from the year-ago figure.
A total of 7 analysts have provided revenue estimates for CDXS’s current fiscal year. The highest revenue estimate was $71M, while the lowest revenue estimate was $58.88M, resulting in an average revenue estimate of $65.38M. In the same quarter a year ago, actual revenue was $70.14M, down -6.80% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $62.05M in the next fiscal year. The high estimate is $72.5M and the low estimate is $51M. The average revenue growth estimate for next year is down -5.10% from the average revenue estimate for this year.
